Graham Holdings (GHC)
NYSEConsumer DiscretionaryConglomeratesSnapshot 2026-11-04
NYSEConsumer DiscretionaryConglomeratesSnapshot 2026-11-04
QuarterlyIQ Insights · GHC
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 4.2% |
| Our one-year growth estimate | diamond | 5.2% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 1.1 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 3 industry peers · Company calendar date is not available
GHC — director transition
Dated 2026-11-05
Director — Robert J. Mylod, Jr.: The filing announces the election of a new independent director to the board, which is a standard governance event and not an executive departure.
Why it matters: Healthcare revenue rose 25% in Q3, but expenses rose 26%. Revenue growth without faster cost growth would support better division results.
Watch forQ4 healthcare revenue grows year over year and its expense growth rate is no higher than revenue growth.
Also watch forQ4 healthcare expenses grow faster than revenue, or revenue falls year over year.
Why it matters: Education revenue fell 14% in Q3, after a 4% drop in Q2. Another decline would deepen pressure on a large division.
Worry ifQ4 education revenue falls year over year, continuing the Q3 decline from $472.7 million to $404.3 million.
Less concerning ifQ4 education revenue grows year over year after the Q3 decline.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$91 on $10,000 · ±0.9% | How much price usually moves either way. |
| Bad day | $234 loss on $10,000 · 2.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $1,300 loss on $10,000 · 13.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.